Susanna Ranta

2.2k total citations
93 papers, 1.6k citations indexed

About

Susanna Ranta is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Susanna Ranta has authored 93 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 21 papers in Public Health, Environmental and Occupational Health and 17 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Susanna Ranta's work include Acute Lymphoblastic Leukemia research (20 papers), Hemophilia Treatment and Research (19 papers) and Blood Coagulation and Thrombosis Mechanisms (18 papers). Susanna Ranta is often cited by papers focused on Acute Lymphoblastic Leukemia research (20 papers), Hemophilia Treatment and Research (19 papers) and Blood Coagulation and Thrombosis Mechanisms (18 papers). Susanna Ranta collaborates with scholars based in Finland, Sweden and Denmark. Susanna Ranta's co-authors include Markku Hynynen, T Tammisto, Aune Hirvasniemi, Mats Heyman, Anna‐Elina Lehesjoki, Albert de la Chapelle, Anne Mäkipernaa, Esa Tahvanainen, Arja Harila‐Saari and T. Conrad Gilliam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Susanna Ranta

85 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanna Ranta Finland 20 431 335 293 229 214 93 1.6k
Walter Krugluger Austria 23 301 0.7× 467 1.4× 207 0.7× 55 0.2× 67 0.3× 87 1.9k
Enrico M. Novelli United States 25 309 0.7× 470 1.4× 990 3.4× 70 0.3× 49 0.2× 95 2.1k
William Krivit United States 21 488 1.1× 318 0.9× 537 1.8× 275 1.2× 140 0.7× 58 1.8k
Michael J. Nash United Kingdom 14 197 0.5× 297 0.9× 208 0.7× 34 0.1× 61 0.3× 38 1.3k
Paul F. Mercer United Kingdom 25 292 0.7× 465 1.4× 170 0.6× 91 0.4× 51 0.2× 58 2.1k
Velu Nair India 16 143 0.3× 362 1.1× 323 1.1× 91 0.4× 25 0.1× 112 1.3k
Vivian Chan China 23 72 0.2× 421 1.3× 332 1.1× 140 0.6× 59 0.3× 70 1.4k
Laura Gutiérrez Spain 21 263 0.6× 401 1.2× 482 1.6× 61 0.3× 74 0.3× 58 1.5k
Nancy Carson Canada 19 67 0.2× 313 0.9× 131 0.4× 102 0.4× 30 0.1× 46 1.2k

Countries citing papers authored by Susanna Ranta

Since Specialization
Citations

This map shows the geographic impact of Susanna Ranta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanna Ranta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanna Ranta more than expected).

Fields of papers citing papers by Susanna Ranta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanna Ranta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanna Ranta. The network helps show where Susanna Ranta may publish in the future.

Co-authorship network of co-authors of Susanna Ranta

This figure shows the co-authorship network connecting the top 25 collaborators of Susanna Ranta. A scholar is included among the top collaborators of Susanna Ranta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanna Ranta. Susanna Ranta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Harila‐Saari, Arja, Susanna Ranta, Hartmut Vogt, et al.. (2025). Infectious Complications During Early Treatment of Childhood Acute Lymphoblastic Leukemia—A Comparison Between the ALLTogether and NOPHO ALL‐2008 Protocols. Pediatric Blood & Cancer. 73(1). e32120–e32120.
3.
Hjalgrim, Lisa Lyngsie, et al.. (2025). Venous thromboembolism in children with Hodgkin lymphoma – A population-based study in Sweden, Finland, and Denmark. Thrombosis Research. 248. 109287–109287. 1 indexed citations
4.
Hjalgrim, Lisa Lyngsie, Pasi Huttunen, Tuukka Niinimäki, et al.. (2024). Radiological follow‐up of osteonecrosis lesions in children and adolescents with Hodgkin lymphoma. British Journal of Haematology. 205(4). 1460–1468.
5.
Hjalgrim, Lisa Lyngsie, Pasi Huttunen, Tuukka Niinimäki, et al.. (2024). Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population‐based study in Sweden, Finland, and Denmark. Pediatric Blood & Cancer. 71(11). e31250–e31250. 2 indexed citations
6.
Baghaei, Fariba, Maria Bruzelius, Pål André Holme, et al.. (2023). No difference in quality of life between persons with severe haemophilia A and B. Haemophilia. 29(4). 987–996. 4 indexed citations
7.
Ranta, Susanna, Jayashree Motwani, Jan Blatný, et al.. (2023). Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres. Haemophilia. 29(5). 1291–1298. 8 indexed citations
8.
Schmidt, David E., Kathelijn Fischer, Jayashree Motwani, et al.. (2022). Long‐term joint outcomes in adolescents with moderate or severe haemophilia A. Haemophilia. 28(6). 1054–1061. 10 indexed citations
9.
10.
Baghaei, Fariba, Maria Bruzelius, Pål André Holme, et al.. (2022). Factor IX antibodies and tolerance in hemophilia B in the Nordic countries – The impact of F9 variants and complications. Thrombosis Research. 217. 22–32. 1 indexed citations
11.
Heyman, Mats, Ólafur Gísli Jónsson, Raheel Altaf Raja, et al.. (2021). Obesity as a predictor of treatment‐related toxicity in children with acute lymphoblastic leukaemia. British Journal of Haematology. 196(5). 1239–1247. 15 indexed citations
12.
Ranta, Susanna, Riitta Niinimäki, Bendik Lund, et al.. (2020). Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocols. European Journal Of Haematology. 105(6). 797–807. 17 indexed citations
13.
Chaireti, Roza, et al.. (2020). Management and outcomes of newborns at risk for inherited antithrombin deficiency. Journal of Thrombosis and Haemostasis. 18(10). 2582–2589. 2 indexed citations
14.
Persson, L., Arja Harila‐Saari, Ida Hed Myrberg, et al.. (2017). Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents. Pediatric Blood & Cancer. 64(10). 19 indexed citations
15.
Schulman, Sam, Michelle Zondag, Lori‐Ann Linkins, et al.. (2015). Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis. Journal of Thrombosis and Haemostasis. 13(6). 1010–1018. 74 indexed citations
16.
Ranta, Susanna, Ruta Tuckuviene, Anne Mäkipernaa, et al.. (2014). Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia – a multicentre study from the Nordic Society of Paediatric Haematology and Oncology. British Journal of Haematology. 168(4). 547–552. 54 indexed citations
17.
Ranta, Susanna & Katarina Pelin. (2007). C.P.1.11 Regulation of nebulin pre-mRNA splicing. Neuromuscular Disorders. 17(9-10). 837–837. 1 indexed citations
18.
Ranta, Susanna, Barbara Ross, Liina Lonka, et al.. (1999). The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nature Genetics. 23(2). 233–236. 247 indexed citations
19.
Ranta, Susanna, et al.. (1994). A gene defect causing a novel progressive epilepsy with mental retardation, EPMR, maps to chromosome 8p. The American Journal of Human Genetics. 55. 2 indexed citations
20.
Ranta, Susanna, et al.. (1985). Assay of adenosine in human adipose tissue. European Journal of Endocrinology. 110(3). 429–432. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walter Krugluger Breakdown of academic impact, for papers by Enrico M. Novelli Breakdown of academic impact, for papers by William Krivit Breakdown of academic impact, for papers by Michael J. Nash Breakdown of academic impact, for papers by Paul F. Mercer Breakdown of academic impact, for papers by Velu Nair Breakdown of academic impact, for papers by Vivian Chan Breakdown of academic impact, for papers by Laura Gutiérrez Breakdown of academic impact, for papers by Nancy Carson
Rankless by CCL
2026